GHRP-2

• This product is for pharmaceutical purpose and research.
• This product is to be used for hormonal disorder under the guidance of pediatrition and dermatologist.

Dosage: Adult: SC Growth hormone deficiency Initial: 6 mcg/kg/day. May increase dose gradually. Max: 12.5 mcg/kg/day. HIV-associated wasting or cachexia 5 mcg/kg/day at bedtime. May take on alternate days for patients at increased risk of adverse effects. Max: 5 mg/day.

Administration: Intramuscular or subcutaneous injection.

Warning: Please stirred properly do not shake.Monitor thyroid function; benign intracranial hypertension. DM; may require dose reduction in insulin. Pregnancy. Discontinue treatment if there is evidence of tumour growth. Monitoring in patients with scoliosis is recommended due to risk of progression of scoliosis.

Storage: Store at room temperature away from heat and direct sunlight prior to mixing. Refrigerate between 2-8’C post Mixing.

Contraindications: Acute critical illness due to heart or abdominal surgery, multiple accidental trauma or respiratory failure; active neoplasms, proliferative or preproliferative diabetic retinopathy; lactation; patients with closed epiphyses. Intracranial lesions. Patients with Prader-Willi syndrome who are severely obese or have severe respiratory impairment.

About: GHRP-2 is a synthetic growth hormone secretagogue that binds to the ghrelin/growth hormone secretagogue receptor. It has been shown in research trials to improve muscle growth, regulate the immune system, and improve sleep cycles. GHRP-2 research has shown that it has oral bio-activity.

What is GHRP-2 ?

GHRP-2 (a.k.a. Pralmorelin) is a synthetic growth hormone secretagogue known to bind to the ghrelin/growth hormone secretagogue receptor. It was the first of the growth hormone secretagogues to be introduced and is currently marketed as a test peptide for the assessment of growth hormone deficiency and secondary adrenal failure. GHRP-2 has been investigated in stage II clinical trials for the assessment of short stature and is under active research for its effects on appetite, muscle growth, the immune system, and sleep cycles. GHRP-2 is orally and sublingually active, so it does not have to be injected to have its effects.